Filing Details
- Accession Number:
- 0001209191-16-126674
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-08 20:34:17
- Reporting Period:
- 2016-06-07
- Filing Date:
- 2016-06-08
- Accepted Time:
- 2016-06-08 20:34:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1592288 | Dimension Therapeutics Inc. | DMTX | Biological Products, (No Disgnostic Substances) (2836) | 463942159 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1653061 | Reed K. Clark | C/O Dimension Therapeutics, Inc. 840 Memorial Drive, 4Th Floor Cambridge MA 02139 | Svp Of Pharmaceutical Develop | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-06-07 | 5,000 | $0.38 | 5,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-06-07 | 5,000 | $10.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2016-06-07 | 5,000 | $0.00 | 5,000 | $0.38 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
114,739 | 2024-04-21 | No | 4 | M | Direct |
Footnotes
- This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- This stock option vests over four (4) years beginning on April 1, 2014, at a rate of twenty-five percent (25%) after 12 months, and in thirty-six (36) equal monthly installments thereafter.